Latebreakers: LMWH gets another indication OK'd

Low molecular weight heparin, enoxaparin (Lovenox, Sanofi-Aventis), has a new indication, the treatment of patients with acute ST-segment elevation myocardial infarction (STEMI).

Related Videos
© 2023 MJH Life Sciences

All rights reserved.